These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4273616)

  • 61. Isoniazid toxicity. Pyridoxine controlled seizures in a dialysis patient.
    Wood ER
    J Kans Med Soc; 1981 Dec; 82(12):551-2. PubMed ID: 7310217
    [No Abstract]   [Full Text] [Related]  

  • 62. [Effect of hyaluronidase on the permeability of the blood-tissue barriers in the complex therapy of patients with pulmonary tuberculosis].
    Khitrina GV; Zakutaeva VP; Tret'iakov AS
    Probl Tuberk; 1971; 49(9):51-5. PubMed ID: 5143430
    [No Abstract]   [Full Text] [Related]  

  • 63. A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance.
    Del Rosso JQ; Bikowski JB; Baum E; Smith J; Hawkes S; Benes V; Bhatia N
    J Drugs Dermatol; 2007 Jun; 6(6):597-600. PubMed ID: 17668525
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 65. [Difficulties in the treatment of pulmonary tuberculosis in a patient rapidly inactivating isoniazid (INH)].
    Bednarski Z
    Wiad Lek; 1984 Jun; 37(12):937-40. PubMed ID: 6523868
    [No Abstract]   [Full Text] [Related]  

  • 66. [Intravenous administration of antitubercular preparations in the complex treatment of patients with pulmonary tuberculosis associated with peptic ulcer].
    Mikhaĭlova ES; Vilenskaia RN; Kanevskaia SS
    Ter Arkh; 1974; 46(5):129-33. PubMed ID: 4428384
    [No Abstract]   [Full Text] [Related]  

  • 67. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E; Abadi O; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):967-74. PubMed ID: 5402999
    [No Abstract]   [Full Text] [Related]  

  • 68. [Treatment of recent pulmonary tuberculosis with combined rifomycin-isoniazid].
    Constans P; Morin Y; Coury C; Bariety M
    Acta Tuberc Pneumol Belg; 1969; 60(3):545-53. PubMed ID: 5371679
    [No Abstract]   [Full Text] [Related]  

  • 69. Isoniazid dosage in patients with renal failure.
    Bowersox DW; Wintebauer RH; Stewart GL; Orme B; Barron E
    N Engl J Med; 1973 Jul; 289(2):84-7. PubMed ID: 4710409
    [No Abstract]   [Full Text] [Related]  

  • 70. [Significance of the isoniazid inactivation in the therapy of pulmonary tuberculosis].
    Gol'dshteĭn VD; Ioffe RA; Ponomareva ES
    Probl Tuberk; 1970; 48(1):34-9. PubMed ID: 5425443
    [No Abstract]   [Full Text] [Related]  

  • 71. The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis.
    Ellard GA
    Tubercle; 1984 Sep; 65(3):211-27. PubMed ID: 6385429
    [No Abstract]   [Full Text] [Related]  

  • 72. [Lupus erythematosus following use of isoniazid].
    Bar-On H
    Harefuah; 1973 Jan; 84(1):25-7. PubMed ID: 4692800
    [No Abstract]   [Full Text] [Related]  

  • 73. [Interrupted treatment with streptomycin and tubazid of patients with pulmonary tuberculosis].
    Ginzburg EA; Levtonova EV; Kaliamova RF; Shilova MV; Samarin MS
    Vrach Delo; 1973 Feb; 2():66-9. PubMed ID: 4722335
    [No Abstract]   [Full Text] [Related]  

  • 74. The effect of isoniazid containing regimen on CYP2E1 during antituberculosis therapy.
    Walubo A; Coetsee C; Arti D; Du Plessis JB
    Res Commun Mol Pathol Pharmacol; 2005; 117-118():137-51. PubMed ID: 18426085
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Isoniazid--the pivot of chemotherapy in tuberculosis.
    Seth V
    Indian Pediatr; 1990 Feb; 27(2):119-23. PubMed ID: 2193884
    [No Abstract]   [Full Text] [Related]  

  • 76. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G; Petitjean R; Schranz J; Scherrer B
    Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
    [No Abstract]   [Full Text] [Related]  

  • 77. Diphenylhydantoin intoxication attendant to slow inactivation of isoniazid.
    Brennan RW; Dehejia H; Kutt H; McDowell F
    Neurology; 1968 Mar; 18(3):283. PubMed ID: 5690351
    [No Abstract]   [Full Text] [Related]  

  • 78. [Early results of sputum-positive patients with newly-detected pulmonary tuberculosis with rifampicin combined with isoniazid and SM (preliminary report)].
    Ropek M; Szymański A; Banaszkiewicz H; Chetkowski A; Czaplińska-Jóźwiak E; Dabrowska-Solecka Z; Ignaczak J; Kondratowicz W; Królikowska H; Pawlik J; Pawlowska I; Sliwińska M; Szuster I; Szymánska W
    Gruzlica; 1973 Jul; 41(7):777-80. PubMed ID: 4730978
    [No Abstract]   [Full Text] [Related]  

  • 79. [Neuropsychiatric repercussions of antitubercular treatment with isoniazid, or isoniazid and ethionamide (apropos of 8 cases)].
    Bleandonu G; Boye J
    Ann Med Psychol (Paris); 1969 Jul; 2(2):201-26. PubMed ID: 5385334
    [No Abstract]   [Full Text] [Related]  

  • 80. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
    Mamolat AS; Bialik IB
    Probl Tuberk; 1969; 47(6):23-8. PubMed ID: 4311969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.